• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vivo-in vitro correlations with a commercial dissolution simulator. I: Methenamine, nitrofurantoin, and chlorothiazide.

作者信息

Yau M K, Meyer M C

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Tennessee Center for the Health Sciences, Memphis 38163.

出版信息

J Pharm Sci. 1981 Sep;70(9):1017-24. doi: 10.1002/jps.2600700913.

DOI:10.1002/jps.2600700913
PMID:6101145
Abstract

Dissolution profiles were determined for nine methenamine, 14 nitrofurantoin, and six chlorothiazide dosage forms using a dissolution simulator. Various in vivo-in vitro correlations were examined. The best correlation for methenamine was between the maximum urinary excretion rate and the time for 15% dissolution. A good correlation for the 50-mg nitrofurantoin tablets was also found between cumulative percent of drug excreted in 12 hr and the percent dissolved in 1 hr. There were no significant correlations for the 100-mg nitrofurantoin dosage forms. Good correlations were also observed for the 250- and 500-mg chlorothiazide tablets between the percent of drug dissolved in 1 min or the time for 15% dissolution and the maximum excretion rate.

摘要

相似文献

1
In vivo-in vitro correlations with a commercial dissolution simulator. I: Methenamine, nitrofurantoin, and chlorothiazide.
J Pharm Sci. 1981 Sep;70(9):1017-24. doi: 10.1002/jps.2600700913.
2
In vitro and in vivo evaluation of seven 50 mg and 100 mg nitrofurantoin tablets.
Biopharm Drug Dispos. 1989 May-Jun;10(3):321-9. doi: 10.1002/bdd.2510100310.
3
In vivo/in vitro correlations of nitrofurantoin matrix tablet formulations.呋喃妥因缓释片制剂的体内/体外相关性
Eur J Drug Metab Pharmacokinet. 1996 Jan-Mar;21(1):27-31. doi: 10.1007/BF03190275.
4
[Role of mass transfer processes in drug formulation].[传质过程在药物制剂中的作用]
Acta Pharm Hung. 1996 May;66(3):105-10.
5
Bioavailability of chlorothiazide tablets in humans.
J Pharm Sci. 1979 Sep;68(9):1099-102. doi: 10.1002/jps.2600680910.
6
A new in vitro/in vivo kinetic correlation method for nitrofurantoin matrix tablet formulations.
Drug Dev Ind Pharm. 2000 Jul;26(7):737-43. doi: 10.1081/ddc-100101292.
7
Thiazides IV: Comparison of dissolution with bioavailability of chlorothiazide tablets.
J Pharm Sci. 1982 Jul;71(7):822-4. doi: 10.1002/jps.2600710727.
8
Clinical bioavaiability of nitrofurantoin--a case of bioinequivalence.呋喃妥因的临床生物利用度——一例生物不等效性案例。
Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):220-7.
9
In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.三种不同市售速释吲达帕胺片的体外-体内相关性
Drug Dev Ind Pharm. 2014 Dec;40(12):1670-6. doi: 10.3109/03639045.2013.842577. Epub 2013 Oct 8.
10
Effect of formulation and process variables on bioequivalency of nitrofurantoin II: in vivo-in vitro correlation.制剂和工艺变量对呋喃妥因II生物等效性的影响:体内-体外相关性
J Pharm Sci. 1978 Nov;67(11):1616-9. doi: 10.1002/jps.2600671129.

引用本文的文献

1
Comparative potency and dissolution performance of internationally available piroxicam products.国际上可获得的吡罗昔康产品的相对效价和溶出性能。
Pharmacoeconomics. 1992;1(Suppl 1):49-52. doi: 10.2165/00019053-199200011-00012.